Goldman warns Vodafone faces risk from VMO2 fibre deal

More in Business

• STAT+: Pharmalittle: We’re reading about AstraZeneca cost-cutting, Sun Pharma facility problems, and more

  Major pharmaceutical manufacturers are navigating operational setbacks and shifting market dynamics across multiple global markets. AstraZeneca is overhauling its balance sheet to counteract revenue losses from impending patent expirations on key treatments, while Sun Pharmaceutical faces severe manufacturing disruptions at a vital production facility. These developments highlight the pressure on drugmakers to balance aggressive pipeline reinvestment with strict regulatory compliance.

  2 min read
• CNA Explains: Will new loan limits for private-hire cars mean less COE demand or higher ride-hailing prices?

  Singapore authorities have moved to eliminate an exploit where motorists registered personal cars under commercial status simply to bypass standard vehicle lending caps. The intervention aims to curtail non-genuine private-hire registrations that surged to hundreds of units each month. Consequently, independent gig drivers now face steep upfront downpayments, stoking fears of escalating operational costs across the ride-hailing sector.

  5 min read
• 5 days left: Your last chance to connect, scale, and save at TechCrunch Founder Summit 2026

  The upcoming gathering, presented by Fidelity Private Shares, offers entrepreneurs access to seasoned investors and operators sharing tactical advice across interactive roundtables and dual breakout stages. Attendees can secure discounted admission and a complimentary guest ticket ahead of imminent door price hikes. This structured programming aims to equip startup founders with the tools necessary to navigate fundraising, enterprise relationships, and sustainable growth.

  4 min read